Precigen Inc [NASDAQ: PGEN] stock went on an upward path that rose over 20.03% on Tuesday, amounting to a one-week price increase of more than 50.11%.
Over the last 12 months, PGEN stock dropped by -16.42%. The one-year Precigen Inc stock forecast points to a potential upside of 78.99. The average equity rating for PGEN stock is currently 1.80, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for the stock reached $328.02 million, with 292.87 million shares outstanding and 147.60 million shares in the current float. Compared to the average trading volume of 989.77K shares, PGEN stock reached a trading volume of 5190550 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Precigen Inc [PGEN]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PGEN shares is $5.33 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PGEN stock is a recommendation set at 1.80. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
JP Morgan have made an estimate for Precigen Inc shares, keeping their opinion on the stock as Underweight, with their previous recommendation back on March 22, 2024. While these analysts kept the previous recommendation, JP Morgan raised their target price to Neutral. The new note on the price target was released on May 23, 2023, representing the official price target for Precigen Inc stock. Previously, the target price had yet another raise to $7, while Cantor Fitzgerald analysts kept a Overweight rating on PGEN stock.
The Average True Range (ATR) for Precigen Inc is set at 0.09, with the Price to Sales ratio for PGEN stock in the period of the last 12 months amounting to 82.83. The Price to Book ratio for the last quarter was 5.92, with the Price to Cash per share for the same quarter was set at 0.10.
PGEN Stock Performance Analysis:
Precigen Inc [PGEN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 50.11. With this latest performance, PGEN shares gained by 20.16% in over the last four-week period, additionally sinking by -24.83% over the last 6 months – not to mention a drop of -16.42% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PGEN stock in for the last two-week period is set at 72.62, with the RSI for the last a single of trading hit 80.20, and the three-weeks RSI is set at 66.74 for Precigen Inc [PGEN]. The present Moving Average for the last 50 days of trading for this stock 0.8404, while it was recorded at 0.8607 for the last single week of trading, and 1.1984 for the last 200 days.
Insight into Precigen Inc Fundamentals:
Precigen Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.63 and a Current Ratio set at 1.63.
PGEN Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for PGEN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Precigen Inc go to 2.40%.
Precigen Inc [PGEN] Institutonal Ownership Details
There are presently around $63.83%, or 71.06%% of PGEN stock, in the hands of institutional investors. The top three institutional holders of PGEN stocks are: PATIENT CAPITAL MANAGEMENT, LLC with ownership of 18.17 million shares, which is approximately 7.2926%. BLACKROCK INC., holding 10.25 million shares of the stock with an approximate value of $$16.19 million in PGEN stocks shares; and BLACKROCK INC., currently with $$10.68 million in PGEN stock with ownership which is approximately 2.7122%.
